The Valley Desk

NCT06093451 · Interventional trial

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Overall registry status Unknown

Phase 4

Conditions Bipolar Disorder, Dexmedetomidine, Schizo Affective Disorder, Schizophrenia Agitation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov